Drug Shortage Report for PEDIATRIX

Last updated on 2023-06-27 History
Report ID 167194
Drug Identification Number 02027798
Brand name PEDIATRIX
Common or Proper name ACETAMINOPHEN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN
Strength(s) 160MG
Dosage form(s) SOLUTION
Route of administration ORAL ORAL
Packaging size 500ML
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-18
Estimated end date 2023-06-20
Actual end date 2023-06-26
Shortage status Resolved
Updated date 2023-06-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-06-27 English Compare
v14 2023-06-26 French Compare
v13 2023-06-26 English Compare
v12 2023-04-27 French Compare
v11 2023-04-27 English Compare
v10 2023-02-16 English Compare
v9 2022-11-14 French Compare
v8 2022-11-14 English Compare
v7 2022-10-28 French Compare
v6 2022-10-28 English Compare
v5 2022-10-17 French Compare
v4 2022-10-17 English Compare
v3 2022-08-19 English Compare
v2 2022-08-18 French Compare
v1 2022-08-18 English Compare

Showing 1 to 15 of 15